Search results for "left ventricular function"

showing 10 items of 15 documents

Hemostatic function in young subjects with central obesity: relationship with left ventricular function.

1995

This study was designed to evaluate coagulation and fibrinolysis activity and their relationship with left ventricular function in young obese subjects with central fat distribution. We assessed coagulation and fibrinolysis activity by evaluation of factor VII activity, fibrinogen and plasminogen, plasminogen activator inhibitor (PAI), and tissue plasminogen activator antigen basally (tPA1) and after venous occlusion (tPA2). These measures were evaluated in young (< 40 years) obese subjects with central fat distribution (n = 19) and in comparable lean subjects (n = 20). Blood glucose, triglycerides, total and high-density lipoprotein (HDL) cholesterol, apolipoprotein (apo) A1 and apo B, fas…

AdultBlood GlucoseMalemedicine.medical_specialtySettore MED/09 - Medicina InternaApolipoprotein BEndocrinology Diabetes and Metabolismmedicine.medical_treatmentFibrinogenVentricular Function LeftSettore MED/15 - Malattie Del Sanguechemistry.chemical_compoundEndocrinologyWaist–hip ratioInternal medicineFibrinolysismedicineHumansInsulinObesityHemostatic functionBlood CoagulationApolipoproteins ATriglyceridesApolipoproteins BHemostasisbiologybusiness.industryCholesterolCholesterol HDLFibrinogenCentral obesity Hemostatic function left ventricular functionPlasminogenFactor VIISettore MED/11 - Malattie Dell'Apparato CardiovascolarePlasminogen InactivatorsEndocrinologychemistrybiology.proteinBody ConstitutionRegression AnalysisFemalebusinessPlasminogen activatormedicine.drugLipoproteinMetabolism: clinical and experimental
researchProduct

Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects

1994

This study was designed to evaluate total (t) and surface (s) beta-adrenergic receptors (BAR) density and their relationships with left ventricular function in young obese subjects. BAR density, plasma insulin, catecholamines and left ventricular function were evaluated in 27 young obese subjects (BMI30.5 kg/m2 for males and27.3 kg/m2 for females) without other risk factors for cardiovascular diseases (smoking, hypertension, diabetes and lipid abnormalities) and in 20 lean controls (BMI25 kg/m2 for males and24.7 kg/m2 for females). Both groups were matched for gender, age and body height. BAR density was evaluated according to Böyum and De Blasi methods. Plasma catecholamines by high perfus…

AdultMaleAgingSettore MED/09 - Medicina InternaRadioimmunoassayPeripheral obesity Central Obesity lymphocyte beta adrenergic receptors left ventricular functionStroke VolumeSettore MED/11 - Malattie Dell'Apparato CardiovascolareVentricular Function LeftCatecholaminesEchocardiographyReceptors Adrenergic betaHumansInsulinRegression AnalysisFemaleLymphocytesObesityCardiac OutputRadionuclide AngiographyChromatography High Pressure Liquid
researchProduct

Human Dental Pulp Stem Cells Improve Left Ventricular Function, Induce Angiogenesis, and Reduce Infarct Size in Rats with Acute Myocardial Infarction

2008

Abstract Human dental pulp contains precursor cells termed dental pulp stem cells (DPSC) that show self-renewal and multilineage differentiation and also secrete multiple proangiogenic and antiapoptotic factors. To examine whether these cells could have therapeutic potential in the repair of myocardial infarction (MI), DPSC were infected with a retrovirus encoding the green fluorescent protein (GFP) and expanded ex vivo. Seven days after induction of myocardial infarction by coronary artery ligation, 1.5 × 106 GFP-DPSC were injected intramyocardially in nude rats. At 4 weeks, cell-treated animals showed an improvement in cardiac function, observed by percentage changes in anterior wall thic…

AdultMalePathologymedicine.medical_specialtyAdolescentAngiogenesismedicine.medical_treatmentMyocytes Smooth MuscleCell- and Tissue-Based TherapyMyocardial InfarctionNeovascularization PhysiologicBiologystem cell therapyventricular remodelingVentricular Function LeftRats Nudeleft ventricular functionDental pulp stem cellsmedicineAnimalsHumansMyocytes CardiacMyocardial infarctionVentricular remodelingDental PulpCell ProliferationUltrasonographymesenchymal stem cellsStem CellsCardiac muscleCell DifferentiationMesenchymal Stem CellsAmniotic stem cellsCell BiologyStem-cell therapyAnatomymedicine.diseasedental pulp stem cellsRatsRetroviridaemedicine.anatomical_structureMolecular MedicineStem cellRetroviridae InfectionsStem Cell TransplantationDevelopmental BiologyStem Cells
researchProduct

Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricul…

1994

This study was designed to evaluate total (t) and surface (s) β-adrenergic receptor (BAR) density and their relationship with central haemodynamics and left ventricular function in young subjects with central or peripheral obesity. A total of 31 obese subjects (BMI ≥30.5 kg. m−2 for males and >27.3 kg. m−2 for females) aged less than 40 years and without other risk factors for cardiovascular diseases (smoking, hypertension, diabetes and lipid abnormalities) were studied. Nine had peripheral obesity and 22 central obesity according to WHR values; there were 20 lean controls (BMI <25 kg. m−2 for males and <24.7 kg. m−2 for females). Casual (c) and 24 h ambulatory mean blood pressures (MBP-24 …

AdultMalemedicine.medical_specialtyCardiac outputSettore MED/09 - Medicina InternaMegalencephalic leukoencephalopathy with subcortical cystsEpinephrineDiastoleHemodynamicsBlood volumeVentricular Function LeftBody Mass IndexNorepinephrineRisk FactorsInternal medicineDiabetes mellitusReceptors Adrenergic betamedicineHumansInsulinLymphocytesObesitySystoleRadionuclide ImagingEjection fractionbusiness.industryHemodynamicsHeartmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCardiovascular DiseasesEchocardiographyBody ConstitutionRegression AnalysisPeripheral obesity Central Obesity Lymphocyte beta adrenergic receptors left ventricular functionFemaleCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

3D echocardiographic reference ranges for normal left ventricular volumes and strain: results from the EACVI NORRE study

2017

International audience; Aim: To obtain the normal ranges for 3D echocardiography (3DE) measurement of left ventricular (LV) volumes, function, and strain from a large group of healthy volunteers. Methods and results: A total of 440 (mean age: 45 ± 13 years) out of the 734 healthy subjects enrolled at 22 collaborating institutions of the Normal Reference Ranges for Echocardiography (NORRE) study had good-quality 3DE data sets that have been analysed with a vendor-independent software package allowing homogeneous measurements regardless of the echocardiographic machine used to acquire the data sets. Upper limits of LV end-diastolic and end-systolic volumes were larger in men (97 and 42 mL/m2)…

AdultMalemedicine.medical_specialtyLongitudinal strainadult echocardiographydeformation imagingHeart VentriclesCardiac VolumeDiastoleEchocardiography Three-Dimensional030204 cardiovascular system & hematologyVentricular Function LeftHeart VentricleReference values03 medical and health sciencesYoung Adultleft ventricular function0302 clinical medicineInternal medicineHealthy volunteersthree-dimensional echocardiographyMedicineCircumferential strainHumansRadiology Nuclear Medicine and imagingReference Value030212 general & internal medicineSystoleAgedEjection fractionStrain (chemistry)business.industryGeneral MedicineMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREMiddle AgedHealthy VolunteerHealthy Volunteers3. Good healthRadiology Nuclear Medicine and imagingReference valuesCardiologyFemale[SDV.IB]Life Sciences [q-bio]/BioengineeringbusinessCardiology and Cardiovascular MedicineHuman
researchProduct

Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity

1992

This study has been designed to evaluate whether duration and severity of obesity can influence left ventricular function response to exercise in obese subjects without other known cardiovascular risk factors such as hypertension, diabetes or hyperlipoproteinemia. A total of 29 obese subjects were included and they were divided, according to their body mass index and to Garrow's criteria as follows: Overweight or mildly obese subjects: body mass index from 25 to 30 kg/m2; moderately obese subjects: body mass index30 and40 kg/m2. Both obese groups were further subdivided according to their duration of obesity evaluated by accurate anamnesis in subgroup A (duration of obesity less than 120 mo…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaHemodynamicsPhysical exerciseOverweightVentricular Function LeftBody Mass IndexElectrocardiographyRisk FactorsLeft ventricular function obesity.Internal medicineDiabetes mellitusmedicineHumansObesityCardiac OutputEjection fractionbusiness.industryHemodynamicsMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareObesityEndocrinologyBlood pressureEchocardiographyExercise TestCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexInternational Journal of Cardiology
researchProduct

Left Ventricular Function Analysis by MDCT: cardiac phase, slice thickness, and number of short-axis sections really change accuracy and time consumi…

2007

CT Coronary Angiography Left Ventricular FunctionSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

64-slice computed tomography assessment of left ventricular volumetric and functional parameters

2006

CT Coronary Angiography left ventricular functionSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients.

2022

Purpose Only a few studies are available on dose-related effects of sacubitril/valsartan (angiotensin receptor neprilysin inhibition (ARNI)) in real-life patients with heart failure and reduced ejection fraction (HFrEF). We sought to investigate clinical and functional effects in real-life HFrEF patients receiving ARNI at a different cumulative dose. Methods This was an observational study in consecutive outpatients admitted for HFrEF from October 2017 to June 2019. The PARADIGM criteria were needed for enrolment. ARNI was uptitrated according to blood pressure, drug tolerability, renal function and kaliemia. At least 10-month follow-up was required in each patient. Clinical assessment, Kan…

Malemedicine.medical_specialtyARNIBlood PressureWalk TestComorbiditySacubitrilVentricular Function LeftAngiotensin Receptor AntagonistsInternal medicinemedicine6-min walking test Aged Aminobutyrates Angiotensin Receptor Antagonists ARNI Biphenyl Compounds Blood Pressure Comorbidity Dose-Response Relationship Drug Drug Combinations Echocardiography Female Heart failure Humans Left ventricular function Male Middle Aged Prospective Studies Sacubitril/valsartan Stroke Volume Valsartan Ventricular Function Left Walk TestHumansPharmacology (medical)Sacubitril/valsartanProspective Studies6-min walking testAgedPharmacologyHeart FailureEjection fractionDose-Response Relationship DrugCumulative dosebusiness.industryAminobutyratesLeft ventricular functionBiphenyl CompoundsStroke VolumeGeneral MedicineMiddle Agedmedicine.diseaseClinical TrialARNI heart failure left ventricular function 6-minutes walking test Sacubitril/valsartan.Drug CombinationsBlood pressureTolerabilityValsartanEchocardiographyHeart failureCardiologyValsartanFemalebusinessSacubitril Valsartanmedicine.drugEuropean journal of clinical pharmacology
researchProduct

Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity.

1992

The present study was carried out to evaluate systolic and diastolic parameters in overweight and moderately obese, but otherwise healthy subjects, and in a lean control group, to determine whether degree and duration of obesity can influence left ventricular function. A total of 27 subjects, 17 overweight or with moderate obesity and 10 lean, healthy subjects were included. Patients were divided into three groups according to their body mass index (BMI) and to Garrow's criteria as follows: lean control group (BMI less than 25 kg.m-2); overweight subjects (BMI from 25 to 30 kg.m-2); moderately obese subjects (BMI greater than 30 less than 40 kg.m-2). Systolic and diastolic parameters were m…

Malemedicine.medical_specialtyMean arterial pressureSettore MED/09 - Medicina InternaTime FactorsSystoleDiastoleBlood PressureOverweightVentricular Function LeftRadionuclide angiographyDiastoleInternal medicinemedicineHumansObesitySystoleEjection fractionmedicine.diagnostic_testbusiness.industryBody WeightInfant Newbornnutritional and metabolic diseasesStroke VolumeStroke volumeMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyLeft ventricular function Systolic function diastolic function peak filling rate obesity radionuclide angiography.CardiologyRegression AnalysisFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexEuropean heart journal
researchProduct